Reducing human suffering by detecting cancer earlier with patented technology

BioCurex's RECAF(tm) marker is found in all types of major cancers

Free
Message: Upcoming presentation by Abbott for Biomarkers in Lung Cancer?

Upcoming presentation by Abbott for Biomarkers in Lung Cancer?

posted on Jan 26, 2009 01:50PM

11.30-13.30.EFFECTIVE USE OF BIOMARKERS FOR LUNG CANCER
(Sponsorized by ABBOTT Diagnostics).

Chairmen:
R. Molina
(Barcelona, Spain)
R. Marrades (Barcelona, Spain)

Tumor marker algorithm for lung cancer
R. Molina, J. M. Auge, J. M. Escudero, N. Viñolas, R. Marrades, E Carcereny, X. Filella
Biochemistry and Molecular Genetics Department. Hospital Clinic. Barcelona (Spain)


Performance of ARCHITECT ProGRP for detection of small cell lung cancer
Petra Stieber (1), Florian Blankenburg (1), Barry Dowell (2), Robert Doss (2), Toru Yoshimura (3), Karin Hofmann (1), Cornelia Scheuer (1), Anne Högg (1), Rudolf Hatz (4)
(1) Institute of Clinical Chemistry, University of Munich, Munich Germany; (2) Abbott Laboratories, Lake County, United States; (3) Abbott Japan, Matsudo, Japan; (4) Surgical Department, University of Munich, Munich, Germany


Diagnostic of cancer from unknown origin by using tumor markers: Improvement including ProGRP
R Molina, J. M. Auge, X. Filella, X. Bosch, J. Ramirez, J. M Escudero, S. Pajares. Laboratory of Clinical Biochemistry (Unit for Cancer Research). Hospital Clínico Provincial. Medical School, Barcelona, Spain.
http://www.oncolab.net/preprogram09....

Share
New Message
Please login to post a reply